These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32035727)

  • 21. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
    Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
    PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
    Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
    Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms.
    Ikonomidis JS; Gibson WC; Butler JE; McClister DM; Sweterlitsch SE; Thompson RP; Mukherjee R; Spinale FG
    Circulation; 2004 Sep; 110(11 Suppl 1):II268-73. PubMed ID: 15364874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SDF-1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy.
    Thomas MN; Kalnins A; Andrassy M; Wagner A; Klussmann S; Rentsch M; Habicht A; Pratschke S; Stangl M; Bazhin AV; Meiser B; Fischereder M; Werner J; Guba M; Andrassy J
    Transpl Int; 2015 Dec; 28(12):1426-35. PubMed ID: 26265085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of adventitial fibroblasts in the early stage of the aortic transplant vasculopathy in rat.
    Ji J; Xu F; Li L; Chen R; Wang J; Hu WC
    Transplantation; 2010 Apr; 89(8):945-53. PubMed ID: 20098355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant.
    Hariya A; Takazawa K; Yamamoto T; Amano A
    J Heart Lung Transplant; 2004 Oct; 23(10):1163-9. PubMed ID: 15477110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model.
    Tanaka A; Hasegawa T; Morimoto K; Bao W; Yu J; Okita Y; Tabata Y; Okada K
    J Vasc Surg; 2014 Sep; 60(3):749-58. PubMed ID: 24011462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis.
    Apparailly F; Noël D; Millet V; Baker AH; Lisignoli G; Jacquet C; Kaiser MJ; Sany J; Jorgensen C
    Arthritis Rheum; 2001 Jun; 44(6):1444-54. PubMed ID: 11407707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic intervention.
    Ryll M; Lei Y; Thomas MN; Li M; Renz B; Wirth U; Kühn F; Bazhin A; Werner J; Anders HJ; Andrassy J
    Transpl Immunol; 2023 Apr; 77():101782. PubMed ID: 36608832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.
    Deng X; He G; Levine A; Cao Y; Mullins C
    Int J Cancer; 2008 Jan; 122(1):209-18. PubMed ID: 17847032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone Induces Tissue Inhibitor of Metalloproteinases-1 Expression and Further Contributes to Collagen Accumulation: From Clinical to Bench Studies.
    Hung CS; Chou CH; Liao CW; Lin YT; Wu XM; Chang YY; Chen YH; Wu VC; Su MJ; Ho YL; Chen MF; Wu KD; Lin YH;
    Hypertension; 2016 Jun; 67(6):1309-20. PubMed ID: 27113051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
    Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
    J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury.
    Dollery CM; Humphries SE; McClelland A; Latchman DS; McEwan JR
    Circulation; 1999 Jun; 99(24):3199-205. PubMed ID: 10377085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo.
    Castoldi G; Di Gioia CR; Pieruzzi F; D'Orlando C; Van De Greef WM; Busca G; Sperti G; Stella A
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H635-43. PubMed ID: 12388255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
    Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
    Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.
    Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M
    Cancer Gene Ther; 2004 Jan; 11(1):73-80. PubMed ID: 14681728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
    Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S
    J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.